Challenges in operationalising clinical trials in India during the COVID-19 pandemic
Year: 2021
Type: article
Abstract: The global outbreak of COVID-19 has had a substantial effect on the conduct of scientific research worldwide. More than 2000 trials registered on ClinicalTrials.gov were terminated because of the challenges of doing clinical research during the pandemic.1 Our research group from the George Institute for Global Health initiated three trials (NCT04483960),2,3 including the hydroxychloroquine prophylaxis evaluation (HOPE) trial in India,2 but encountered several challenges that were unique to India in terms of the operationalisation and execution of these trials.
Source: The Lancet Global Health
Authors: Abhinav Bassi, Sumaiya Arfin, Rohina Joshi, Nikita Bathla, Naomi E Hammond, Dorrilyn Rajbhandari, Bharath Kumar Tirupakuzhi Vijayaraghavan, Balasubramanian Venkatesh, Vivekanand Jha
Institutions: George Institute for Global Health, UNSW Sydney, The George Institute for Global Health, Royal North Shore Hospital, Apollo Hospitals, Apollo Hospitals, Apollo Hospitals, Apollo Hospitals, The University of Queensland, Wesley Hospital, Manipal Academy of Higher Education, The George Institute for Global Health, Imperial College London
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $5,000
OpenAlex ID: W4200221663